Cover Image
Market Research Report

Contract Research Outsourcing

Published by Global Industry Analysts, Inc. Product code 503813
Published Content info 282 Pages
Delivery time: 1-2 business days
Price
Back to Top
Contract Research Outsourcing
Published: February 1, 2018 Content info: 282 Pages
Description

This report analyzes the worldwide markets for Contract Research Outsourcing in US$ Million by the following Service Segments: Drug Discovery, Preclinical Research, and Clinical Research. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 115 companies including many key and niche players such as -

Albany Molecular Research, Inc.
Charles River Laboratories International, Inc.
Chiltern International Ltd.
ICON plc
INC Research, LLC

Table of Contents
Product Code: MCP-1534

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Outsourcing of R&D Projects to Propel CROs Services Market
  • Growth Drivers in a Nutshell
  • Evolving Macro Trends Driving CRO Demand
  • CROs to Significantly Drive Outsourcing Penetration
  • Focus on Efficient, Quality Services to Drive Specialty CROs Market
  • Rise in Investments to Boost Growth
  • Key Therapeutic Areas of Clinical Trial Research
    • Table 1: Global Clinical Trial Services Market by Therapeutic Area: 2016 (includes corresponding Graph/Chart)
  • Primary Factors Influencing CRO Market
  • Pharma and Biotech Companies to Increase Dependence on CROs
  • Outlook
  • Notable Regional Developments
  • Future Model of CRO

2. COMPETITIVE SCENARIO

  • CRO - A Highly Fragmented Market
    • Table 2: Leading Players in the Global Contract Research Outsourcing Market (2016E): Percentage Breakdown of Revenues by Player (includes corresponding Graph/Chart)
    • Table 3: Percentage Breakup of Life Sciences Revenues (2016) of Major Players by Service Type- Preclinical, Phase I, Phase IIA, Phase IIB, Phase III, Phase IV/ Post-Approval, Central Lab and Others
  • Large CROs Seek the Inorganic Growth Route
  • Global CRO Marketspace - A Review of the M&A Activity in the Recent Years
  • Select M&A Activity in the Global CRO Market
  • Noteworthy Contracts of Major CROs
  • CROs Adept with New Technologies to See More Business in Future
  • Streamlining Development of Novel Trial Designs
  • CROs with End-to End Capabilities in Demand
  • Key Opportunities for CROs
  • Technological Superiority - A Definite Advantage
  • Strategies and Tactical Programs for CROs
  • Survival Strategies in Mature CRO Markets
  • Strategies to Tap Opportunities in Growing Markets

3. GROWTH DRIVERS, MARKET TRENDS & ISSUES

  • Increased Spend on R&D Outsourcing
    • Table 4: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2017 (includes corresponding Graph/Chart)
    • Table 5: Percentage Breakdown of Total Number of Compounds in Pipeline by Phase for Pre-Clinical, Phase I, Phase II and Phase III: 2016E (includes corresponding Graph/Chart)
  • Enhancing Site Selection and Patient Enrollment
  • CROs Enter into Alliances to Improve Efficiencies
  • Adoption of Digital Technologies Gains Pace
  • Rising Late-Stage Services Demand and Budget Restraints Drive Market Growth
  • Toxicology Services Gain Notable Attention
  • Pharma Companies Enter into Licensing Agreements with Biotech Companies for New Drug Discovery - A Mutually Beneficial Strategy
  • Pharmaceutical & Biopharmaceutical Trends to Support CRO Penetration
    • Table 6: Global Biopharma % R&D Outsourcing (2014-2020) (includes corresponding Graph/Chart)
    • Table 7: New FDA Drug Approvals (2010-2016): Breakdown of Number of Approvals by Type for New Molecular Entity (NME) and Biologic License Application (BLA) Approvals (includes corresponding Graph/Chart)
  • Focus on Regulatory Oversight and Enhanced Transparency Bodes Well for CROs
  • eClinical Solutions Gain Traction
  • Other Noteworthy Market Trends
  • CROs Monetize Data
  • Service Differentiation - A Sustaining Strategy
  • CROs Tie Up with Diagnostic Companies for Patients
  • Research Networks Move to Cloud
  • Application of Mobile Devices to Collect Real Time Data Gains Ground
  • CROs Provide Exclusive Offers to Lure Big Pharma
  • Challenges Faced by Contract Research Organizations
  • On-shore versus Offshore CRO Business
  • Cutthroat Competition among CROs
  • Management of Clinical Investigation
  • Cost Containment
  • Safety Concerns on Clinical Trials
  • Pipeline Blocks
  • Surging Global Population Offers Increased Growth Opportunities
    • Table 8: Top 25 Countries Worldwide in Terms of Population: 2015 & 2016 (In Million) (includes corresponding Graph/Chart)
  • Aging Population Boosts Opportunities for CRO
    • Table 9: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart)
    • Table 10: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart)
  • Increasing Healthcare Expenditure to Spur Demand for Generics
    • Table 11: Healthcare Spending as a Percentage of GDP by Region (2016E) (includes corresponding Graph/Chart)

4. CONTRACT RESEARCH OUTSOURCING - AN INSIGHT

5. RECENT INDUSTRY ACTIVITY

  • WuXi AppTec Takes Over HD Biosciences
  • Laboratory Corporation of America Holdings to Acquire Pharmaceutical Product Development
  • PRA Health Sciences and Takeda Pharmaceutical Inks New Partnership
  • AMRI Enters into Alliance with Bruker Daltonics and HighRes Biosolutions
  • Pharmaceutical Product Development Establishes Rare Disease and Pediatric Center of Excellence
  • Pharmaceutical Product Development to Start Clinical Research Unit in Las Vegas
  • Bracket Acquires CLINapps
  • PAREXEL International to Acquire ExecuPharm
  • Cinven to Takeover BioClinica
  • ICON to Takeover Clinical Research Management
  • Pharmaceutical Product Development Acquires Evidera
  • Velocity Fund Partners Acquires Indipharm
  • Bioclinica Snaps Up Compass Research
  • Charles River Laboratories International Takes Over Agilux Laboratories
  • Charles River Laboratories International Snaps Up Blue Stream Laboratories
  • Charles River Laboratories International Acquires WIL Research
  • Pharmaron Announces the Acquisition of Quotient Bioresearch
  • Amulet Capital Partners Acquires SynteractHCR Holdings
  • IMS Health Merges with Quintiles
  • Almac Clinical Technologies Enters into Partnership with inVentiv Health
  • CSSi LifeSciences Unveils Fully Integrated Medical Device CRO
  • Lovelace Biomedical Commences Operations as Preclinical CRO
  • PAREXEL International Inks Services Agreement with Pfizer
  • BioDuro Commences Operations as a Contract Research and Manufacturing Firm
  • Charles River Laboratories International Forms Partnership with BioMotiv
  • Laboratory Corporation of America Acquires Covance
  • Charles River Laboratories International Snaps Up Oncotest
  • Chiltern Acquires Theorem Clinical Research
  • Charles River Laboratories International Takes Over Celsis International
  • Albany Molecular Research Unveils Integrated Drug Discovery Center

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Albany Molecular Research, Inc. (USA)
  • Charles River Laboratories International, Inc. (USA)
  • Chiltern International Ltd. (UK)
  • ICON plc (Ireland)
  • INC Research, LLC (USA)
  • InVentiv Health, Inc. (USA)
  • Jubilant Biosys Ltd. (India)
  • Laboratory Corporation of America(r) Holdings (USA)
  • PAREXEL International Corp. (USA)
  • Pharmaceutical Product Development, LLC. (USA)
  • Pharmaron (China)
  • PRA Health Sciences, Inc. (USA)
  • Quintiles IMS Holdings, Inc. (USA)
  • Ricerca Biosciences LLC (USA)
  • Sygnature Discovery Limited (UK)
  • SynteractHCR (USA)
  • WuXi AppTec (China)

7. GLOBAL MARKET PERSPECTIVE

    • Table 12: World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Contract Research Outsourcing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for Contract Research Outsourcing for Drug Discovery by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for Contract Research Outsourcing for Drug Discovery by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Preclinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Contract Research Outsourcing for Preclinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for Contract Research Outsourcing for Preclinical Research by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 21: World Recent Past, Current & Future Analysis for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for Contract Research Outsourcing for Clinical Research by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for Contract Research Outsourcing for Clinical Research by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest of World Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Drug Developers Rely on CROs to Improve Trial Efficiency and Cost Savings
    • Trial Services Witness Higher Demand
    • Strong Demand for Data Management Services
    • Focus on Innovation and Productivity
    • CROs Focus on Adaptive Clinical Trials
    • Risk-based Monitoring Catches Pace
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 24: US Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 25: US Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 26: US 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

2. CANADA

  • Market Analysis
    • Table 27: Canadian Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 28: Canadian Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 29: Canadian 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 30: Japanese Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 31: Japanese Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 32: Japanese 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Providers Expand Services in Downstream Drug Development
    • Strategic corporate developments
    • Key Players
  • B. Market Analytics
    • Table 33: European Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 34: European Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 35: European 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Asia-Pacific to Push up Volume Share in CRO Market
    • R&D Outsourcing in Life Sciences on Rise
    • Focus on Select Regional Markets
      • China
      • India
      • Australia
      • Superior Clinical Trial Quality
    • Strategic Corporate Development
    • Key Players
  • B. Market Analytics
    • Table 36: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 37: Asia-Pacific Historic Review for Contract Research Outsourcing by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 38: Asia-Pacific 14-Year Perspective for Contract Research Outsourcing by Geographic Region - Percentage Breakdown of Revenues for China, India and Rest of Asia-Pacific Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
    • Table 39: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 40: Asia-Pacific Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 41: Asia-Pacific 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Providers with Specialized Research Techniques to Boost Latin American CRO Market
  • B. Market Analytics
    • Table 42: Rest of World Recent Past, Current & Future Analysis for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)
    • Table 43: Rest of World Historic Review for Contract Research Outsourcing by Service Type - Drug Discovery, Preclinical Research and Clinical Research Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart)
    • Table 44: Rest of World 14-Year Perspective for Contract Research Outsourcing by Service Type - Percentage Breakdown of Revenues for Drug Discovery, Preclinical Research and Clinical Research Markets for Years 2009, 2017 & 2022 (includes corresponding Graph/Chart)
Back to Top